Figure 1From: Design and synthesis of the first NO- and haem-independent sGC activator BAY 58–2667 for the treatment of acute decompensated heart failureDiscovery of sGC activators via ultra-high throughput screening using sGC-overexpressing CHO cell lines.Back to article page